Weight-loss medication like semaglutide and tirzepatide could assist shrink waistlines, however new analysis exhibits they fail to spice up health and may trigger severe muscle loss, probably undermining the long-term well being advantages of slimming down.
For all of their pluses, we all know {that a} main facet impact of the favored GLP-1RA injectable weight reduction medication is that the fast and important weight reduction they produce is accompanied by a notable loss of fat-free mass, or muscle.
New analysis led by the College of Virginia Well being (UVA Well being) has critically examined the consequences of widespread GLP-1 receptor agonist medication (GLP-1RAs) and twin GLP-1/GIP receptor agonists (GLP-1/GIPRAs), similar to semaglutide and tirzepatide, on cardiorespiratory health and muscle well being.
“Some sufferers actually advised me that they felt that they have been dropping muscle or muscle was slipping away from them whereas they have been on these drugs,” mentioned lead and corresponding writer Zhenqi Liu, MD, Professor of Medication and Professor of Diabetes on the UVA School of Medicine. “It is a severe concern. Muscle, particularly axial muscle, is crucial for posture, bodily perform and general well-being.
“Dropping lean physique mass can enhance the danger of heart problems, all-cause mortality and diminished high quality of life. We have to make it possible for sufferers prescribed these drugs aren’t already in danger for malnutrition or low muscle mass.”
Whereas common age-related muscle loss (sarcopenia) is round 8% per decade, the loss induced by these drugs can account for 25% to 40% of the full weight misplaced. The researchers got down to higher perceive the potential long-term penalties of this muscle loss, so that they reviewed the accessible knowledge on the drugs’ results on cardiorespiratory health (CRF).
CRF, often known as cardiovascular health, refers back to the physique’s skill to ship oxygen to skeletal muscle mass for the vitality manufacturing required throughout bodily exercise. The gold-standard measure of CRF is maximal oxygen consumption, or VO2max. Increased VO2max values point out higher CRF, reflecting the physique’s skill to make use of oxygen effectively – that’s, take it from the air, perfuse it into the bloodstream and ship it to the tissues – throughout train. Why is CRF so vital? As a result of it’s been proven to be a stronger predictor of mortality than weight alone.
“Cardiovascular health is a potent predictor of all-cause and cardiovascular mortality threat throughout a variety of populations, together with weight problems, diabetes and coronary heart failure,” mentioned Siddhartha Angadi, PhD, affiliate professor of kinesiology at UVA’s Faculty of Schooling and Human Growth, and the research’s co-corresponding writer. “In a recent study by our group that examined mortality outcomes from nearly 400,000 people internationally, we discovered that CRF was far superior to obese or weight problems standing for predicting the danger of demise. In truth, as soon as CRF was factored in, physique weight did not predict the danger of mortality. This is the reason it’s so vital to grasp the consequences of this new class of medicine on it.”
Within the current research the researchers discovered that whereas these medication induced appreciable weight reduction, a considerable portion of this weight reduction got here from muscle, which is problematic. Regardless of advantages to some cardiovascular measures and (clearly) weight reduction, these medication didn’t enhance VO2max. They’re urging additional analysis to be undertaken to raised perceive the consequences of the medication and guarantee sufferers get the absolute best outcomes.
Newer iterations of injectable weight reduction medication seem to not have the identical drastic impact on muscle mass, however they’re nonetheless present process clinical trials. For the second, the researchers are urging people taking or contemplating taking GLP-1RAs or twin GLP-1/GIPRAs to talk with a medical skilled in regards to the concern of muscle loss.
“That is an space of energetic analysis, and we’re hopeful that higher options are coming quickly,” mentioned Liu. “However for now, it will be important that sufferers prescribed GLP-1 medication have conversations with their healthcare suppliers about methods to protect muscle mass. The American Diabetes Affiliation recommends screening for malnutrition and low muscle mass threat earlier than beginning these drugs and selling satisfactory protein consumption and common train all through therapy.”
Moreover, additional research is required to look at whether or not exercising whereas taking GLP-1 remedy impacts cardiovascular health.
“Lastly, train coaching throughout GLP-1 remedy stays to be assessed in its skill to protect or enhance VO2max throughout GLP-1 remedy,” Angadi mentioned.
The research was printed in The Journal of Clinical Endocrinology & Metabolism.
Supply: UVA Health
